What is Glucobit?
Glucobit operates at the intersection of mobile technology and behavioral health, offering a comprehensive recovery program designed to assist users in quitting alcohol. By digitizing the support and tools typically found in clinical settings, the company provides a scalable, user-centric alternative that meets the growing demand for accessible mental health and addiction recovery resources. Its market position is defined by a commitment to evidence-based digital interventions, aiming to bridge the gap between professional care and daily habit management. As the digital health landscape continues to evolve, Glucobit's focus on high-engagement mobile tools places it in a unique position to capture significant market share among health-conscious consumers and enterprise wellness programs.
How much funding has Glucobit raised?
Glucobit has raised a total of $13.9M across 2 funding rounds:
Angel/Seed
$1.4M
Series A
$12.5M
Angel/Seed (2021): $1.4M with participation from Atlanta Ventures, Kyle Porter, Dave Harrington, and Chris Klaus
Series A (2022): $12.5M led by Goodwater Capital and Atlanta Ventures
Key Investors in Glucobit
Goodwater Capital
Goodwater Capital is a consumer tech investment firm that empowers exceptional entrepreneurs to create positive change in the world, focusing on innovative companies across financial services, retail, and healthcare.
Atlanta Ventures
Atlanta Ventures empowers entrepreneurs in the Southeastern United States by providing community, content, and capital to help them launch and grow their companies, with a focus on subscription-based business models.
Chris Klaus
Chris Klaus is an experienced technology investor and entrepreneur known for supporting early-stage ventures that drive innovation in the digital and software sectors.
What's next for Glucobit?
Looking ahead, the strategic deployment of $12.5M will likely focus on scaling user acquisition and deepening the clinical efficacy of the Glucobit platform. The company is expected to prioritize product development, potentially integrating advanced data analytics to personalize recovery journeys for its growing user base. Furthermore, the backing from prominent venture firms suggests a roadmap that may include strategic partnerships with healthcare providers and insurance entities, aiming to integrate the app into broader health management ecosystems. As Glucobit matures, the focus will shift toward long-term retention and demonstrating measurable health outcomes, which will be critical for securing future growth capital and establishing the company as a leader in the digital recovery space.
See full Glucobit company page
